Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

New ultrasound criteria for diagnosing PCOS in North African patients were successfully established.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

Dermoscopy is useful for many health professionals, not just dermatologists, in improving skin condition diagnoses and reducing unnecessary biopsies.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

Older age, higher BMI, and family history of diabetes increase the risk of gestational diabetes in pregnant women.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

Pilomatrixoma is a rare, harmless tumor near the eyebrow in kids, best treated with surgery.

Some skin growths with mucin can form hair follicles and resemble skin cancer, but a special stain can help tell them apart.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

PSA can help diagnose high androgen levels in women.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

The study concluded that examining the scalp with a special magnifying device helps diagnose the cause of widespread hair loss in adult women.

The study introduced a new imaging technology to track skin healing and bone marrow cell activity over time.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Thick scalp melanoma can be hard to diagnose because it often looks like other skin conditions.

The treatment is safe and shows promise for metastatic breast cancer.

Rind-based techniques can lower scalp radiation dose and reduce hair loss in brain cancer treatment.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

A 29-year-old man had a jaw plaque diagnosed as follicular mucinosis, linked to nestin-positive hair follicle stem cells.

Trichoepithelioma and desmoplastic trichoepithelioma have distinct features that can be identified using reflectance confocal microscopy.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.